SB-399885_hydrochloride_LCMS_27506_MedChemExpress
MK2-IN-1_hydrochloride_SDS_MedChemExpress
Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:Jul.-24-2017Print Date:Jul.-24-20171. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :MK2-IN-1 (hydrochloride)Catalog No. :HY-12834ACAS No. :1314118-94-91.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:MK2 InhibitorFormula:C27H26Cl2N4O2Molecular Weight:509.43CAS No. :1314118-94-94. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance Pink to red (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is considered to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。
CelLyticTM系列蛋白裂解液
高效率 操作步骤简单,省时 高得率 得率远优于传统冻融或超声法 高活性 温和非变性条件下抽提活性蛋白 高兼容 与蛋白酶抑制剂、鳌合剂、离液剂等很好兼容 抽提的蛋白无需去除CelLyticTM 试剂即可进行下游实验： 亲和纯化 Western blot 凝胶迁移检测 报告基因检测……
566.28 2136.42 566.28 3758.04 2535.39 3938.22
501.93 3320.46
566.28 2084.94 3989.7
527.67 3629.34 5302.44
促销价¥
384.81 2375.80 685.97 2375.80 409.91 1505.79 2651.86 1054.05 1648.00 393.18 1187.90 217.50 711.07 4341.69 368.08 1271.56
哺乳动物细胞和组织裂解
C2978
CelLytic™ M Cell Lysis Reagent
C3228
CelLytic™ MT Cell Lysis Reagent
CE0500 NXTRACT
R0278
CelLytic™ MEM Protein Extraction Kit CelLytic™ NuCLEAR™ Extraction Kit For mammalian tissue or cultured cells RIPA Buffer
P8215
Protease Inhibitor Cocktail for use with fungal and yeast extracts
P8465
Protease Inhibitor Cocktail for use with bacterial cell extracts
MedBio_169505-93-5_RS 17053 hydrochloride物理说明
MDL 100907
139290-65-6
50mg
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED12962
α-Methyl-5-hydroxytryptamine maleate
α-Methyl-5-hydroxytryptamine maleate
97469-12-0
体内研究
RS 17053盐酸盐具有快速起效，并且作用持续时间超过60分钟。RS 17053盐酸盐预处理显着改变食物摄入量[F（4,132）5 6.28，p，0.0001]。10 mg / kg RS-17053显着抑制食物摄入[2]。
3、同类产品列表：
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MedBio
1、产品物理参数：
常用名
RS 17053盐酸盐
英文名
RS 17053 hydrochloride
CAS号
169505-93-5
分子量
449.41300
密度
无资料
沸点
580.1ºC at 760 mmHg
分子式
C24H30Cl2N2O2
熔点
无资料
闪点
304.7ºC
2、技术资料：
体外研究
在来自大鼠和克隆的肾上腺素能受体的几种组织中，RS 17053盐酸盐对α1A-肾上腺素受体具有高亲和力（pKi和pA2估计值为9.1-9.9），并且比α1B和α1D-肾上腺素能受体亚型具有30-100倍的选择性（pKi和pA2估计值为7.7-7.8）。然而，在来自人LUT组织的分离的平滑肌制剂中，RS 17053盐酸盐仅在高浓度下拮抗对NE的反应。调节NE诱导的收缩的α1-肾上腺素能受体的亲和力（pA2）在前列腺尿道纵向平滑肌中为7.5（哌唑嗪为8.6），前纤维肌肉基质为6.9（哌唑嗪，8.9），膀胱颈为7.1（哌唑嗪，8.5）[1]。
超氧化物歧化酶（SOD）活性检测试剂盒说明书
Beijing Solarbio Science & Technology Co., LtdTel: 400-968-6088超氧化物歧化酶（SOD）活性检测试剂盒说明书微量法注意：本产品试剂有所变动，请注意并严格按照该说明书操作。
货号：BC0175规格：100T/48S产品组成：使用前请认真核对试剂体积与瓶内体积是否一致，有疑问请及时联系索莱宝工作人员。
试剂名称规格保存条件提取液液体110 mL×1瓶2-8℃保存试剂一液体5 mL×1瓶2-8℃保存试剂二液体100 μL×1支2-8℃保存试剂三液体4 mL×1瓶2-8℃保存试剂四液体0.25mL×1支2-8℃保存溶液的配制：1、试剂二：使用前先离心再吹打混匀。
根据样本量将试剂二用蒸馏水稀释10倍后使用，当天用完。
2、试剂四：根据样本量将试剂四用蒸馏水稀释5倍后使用，当天用完。
产品说明：SOD（EC 1.15.1.1）广泛存在于动物、植物、微生物和培养细胞中，催化超氧化物阴离子发生歧化作用，生成H2O2和O2。
SOD不仅是超氧化物阴离子清除酶，也是H2O2主要生成酶，在生物抗氧化系统中具有重要作用。
通过黄嘌呤及黄嘌呤氧化酶反应系统产生超氧阴离子(O2-)，O2-可还原氮蓝四唑生成蓝色甲臜，后者在560nm 处有吸收；SOD可清除O2-，从而抑制了甲臜的形成；反应液蓝色越深，说明SOD活性愈低，反之活性越高。
注意：实验之前建议选择2-3个预期差异大的样本做预实验。
如果样本吸光值不在测量范围内建议稀释或者增加样本量进行检测。
需自备的仪器和用品：可见分光光度计/酶标仪、台式离心机、可调式移液器、微量玻璃比色皿/96孔板、细胞超声破碎仪、研钵/匀浆器、冰和蒸馏水。
操作步骤：一、样本处理（可适当调整待测样本量，具体比例可以参考文献）1.细胞、细菌样本：先收集细菌或细胞到离心管内，离心后弃上清，按照每500万细菌或细胞加入1mL提取液，超声波破碎（功率200w，超声3s，间隔10s，重复30次）。
碧云天生物技术 DEPC水(DNase、RNase free) 说明书
碧云天生物技术/Beyotime Biotechnology 订货热线：400-1683301或800-8283301 订货e-mail ：******************技术咨询：*****************网址：碧云天网站 微信公众号DEPC 水(DNase 、RNase free)产品编号 产品名称包装 R0022DEPC 水(DNase 、RNase free)500ml产品简介：碧云天生产的DEPC 水，即DEPC-treated Water ，是用DEPC(diethypyrocarbonate ，焦碳酸二乙酯)处理过并经高温高压消毒的Milli-Q 纯水。
经检测不含RNase 、DNase 和proteinase 。
DEPC 水可以用于RNA 沉淀的溶解，含有RNA 的各种反应体系如反转录、siRNA 的退火等，以及其它各种要求无RNase 、DNase 和proteinase 的反应体系。
DEPC 水不同于DEPC 。
DEPC 水是使用DEPC 处理过的水，基本上不含DEPC ，99.99%以上是水。
如需购买用于去除RNA 酶的DEPC ，可以选购碧云天的DEPC(ST036)。
包装清单：产品编号 产品名称包装 R0022 DEPC 水(DNase 、RNase free)500ml —说明书1份保存条件：室温保存，一年有效。
注意事项：如果每次的使用量很小，可以适当分装后再使用。
手上通常有RNase ，必须戴一次性手套操作，以防RNase 污染。
本产品仅限于专业人员的科学研究用，不得用于临床诊断或治疗，不得用于食品或药品，不得存放于普通住宅内。
为了您的安全和健康，请穿实验服并戴一次性手套操作。
相关产品：产品编号 产品名称包装 R0021 DEPC 水(DNase 、RNase free) 100ml R0022 DEPC 水(DNase 、RNase free)500ml ST036DEPC10g使用本产品的文献：1. Xu F, Yang T, Chen Y . Quantification of microRNA by DNA–Peptide Probe and Liquid Chromatography–Tandem Mass Spectrometry-Based Quasi-TargetedProteomics. Anal Chem. 2016 Jan 5;88(1):754-63. 2. Zheng Y , Liang W, Yuan Y , Xiong C, Xie S, Wang H, Chai Y , Yuan R. Wavelength-resolved simultaneous photoelectrochemical bifunctional sensor on singleinterface: A newly invitro approach for multiplexed DNA monitoring in cancer cells. Biosens Bioelectron. 2016 Jul 15;81:423-30.3. Zheng X, Pang X, Yang P, Wan X, Wei Y , Guo Q, Zhang Q, Jiang X. A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloidplaque targeting inAlzheimer's disease mice. Acta Biomater. 2017 Feb;49:388-401.4. Liu L, Xu Q, Hao S, Chen Y .A Quasi-direct LC-MS/MS-based Targeted Proteomics Approach for miRNA Quantification via a Covalently ImmobilizedDNA-peptide Probe.Sci Rep-Uk . 2017 Jul 18;7(1):5669. 5. Xu F, Zhou W, Cao J, Xu Q, Jiang D, Chen Y .A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS):A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification.Theranostics . 2017 Jul 8;7(11):2849-2862. 6. Zheng X, Pang X, Yang P, Wan X, Wei Y , Guo Q, Zhang Q, Jiang X.A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloidplaquetargeting in Alzheimer's disease mice.Acta Biomater . 2017 Feb;49:388-401. 7. Guo S, Meng XW, Yang XS, Liu XF, Ou-Yang CH, Liu C.Curcumin administration suppresses collagen synthesis inthe hearts of rats withexperimentaldiabetes.Acta Pharmacol Sin . 2018 Feb;39(2):195-204. 8. Han B,Zhang Y ,Zhang Y ,Bai Y ,Chen X,Huang R,Wu F,Leng S,Chao J,Zhang JH,Hu G,Yao H.Novel insight into circular RNA HECTD1 in astrocyteactivation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke.Autophagy . 2018;14(7):1164-1184. 9. Xu L,Yu QW,Fang SQ,Zheng YK,Qi JC.MiR-650 inhibits the progression of glioma by targeting FAM83F.Eur Rev Med Pharmaco . 2018 Dec;22(23):8391-8398. 10. Yu C,Zhang X,Sun X,Long C,Sun F,Liu J,Li X,Lee RJ,Liu N,Li Y ,Teng LKetoprofen and MicroRNA-124 Co-loaded poly (lactic-co-glycolic acid)microspheres inhibit progression of Adjuvant-induced arthritis in rats.Int J Pharmacol . 2018 Dec 1;552(1-2):148-153. 11. Guo S,Meng XW,Yang XS,Liu XF,Ou-Yang CH,Liu CCurcumin administration suppresses collagen synthesis in the hearts of rats with experimentaldiabetes.Acta Pharmacol Sin . 2018 Feb;39(2):195-204.12.Xie Y,Hu JZ,Shi ZYMiR-181d promotes steroid-induced osteonecrosis of the femoral head by targeting SMAD3 to inhibit osteogenic differentiation ofhBMSCs.Eur Rev Med Pharmaco . 2018 Jul;22(13):4053-4062.13.Kang Q,Zou H,Zhou L,Liu LX,Cai JB,Xie N,Li WH,Zhang C,Shi WH,Wang LM,Zhang WH,Zhu H,Wang SF,Zhang XWRole of the overexpression ofTRAF4 in predicting the prognosis of intrahepatic cholangiocarcinoma.Int J Oncol . 2018 Jul;53(1):286-296.14.Wang P,Chen Y,Wang L,Wu Y,Wang L,Wu Y,Gong Z.The intervention mechanism of folic acid for benzo(a)pyrene toxic effects in vitro and in vivo.Eur JCancer Prev . 2018 Jul 16.15.Cai Y,Dong ZY,Wang JY.MiR-520b inhibited metastasis and proliferation of non-small cell lung cancer by targeting CHAF1A.Eur Rev Med Pharmaco . 2018Nov;22(22):7742-7749.16.Pan SC,Cui HH,Qiu CGHOTAIR promotes myocardial fibrosis through regulating URI1 expression via Wnt pathway.Eur Rev Med Pharmaco . 2018Oct;22(20):6983-6990.17.Protective effect of cyclosporine on inflammatory injury of renal tubular epithelial cells.Eur Rev Med Pharmaco. 2018 Oct;22(19):6551-6559.Version 2020.03.232 / 2 R0022DEPC水(DNase、RNase free) 400-1683301/800-8283301 碧云天/Beyotime。
组织硫化氢含量比色法定量检测试剂盒产品说明书
技术背景
硫化氢（hydrogen sulfide；H2S）是一种自然发生的，具有腐蚀性和可燃性，不稳定的易被氧化的无色气体， 为半胱氨酸脱硫（desulfuration）代谢产物，是第三个生理性气体信使分子（messenger molecule）或气体传 导分子（gasotransmitter），存在于脑、心脏、肺、肝、小肠、胰腺以及海绵体（cavernosum）组织等，其中 脑组织含量较低，肾组织含量较高。神经系统的胱硫醚-β-合成酶（Cystathionine-β-synthase；CBS）和心血 管系统的胱硫醚-γ-裂解酶（cystathionine γ-lyase；CGL）是参与内源性硫化氢生成的主要成员。一旦机体缺 氧，硫化氢含量即增高。硫化氢旨在调节组织内含硫氨基酸的水平，具有心血管系统的生理功能和病理生 理调节作用，例如诱导血管平滑肌松弛，血管扩张（vasodilation），致血压下降，以及促炎性作用。同时硫 化氢具有毒性作用，会造成嗅觉神经迅速瘫痪，抑制细胞色素C氧化酶，增加线粒体膜通道孔开放，引起 心脏、小肠、生殖系统、泌尿系统和呼吸系统平滑肌过度松弛，而产生器官损伤、低血压、心动过缓 （bradycardia）等症状。在自然环境中，硫化氢是硫循环（sulfur cycle）的主要中间产物，包括有机硫化物 的矿物化或分解、微生物的同化作用，以及氧化还原。作为化学窒息性（asphyxiant）气体，硫化氢对于鱼 类和其它水生动物具有毒性作用，同时也是细菌污染的标志。使用醋酸锌（zinc acetate）在碱性条件下， 捕获硫化氢，形成稳定的硫化锌沉淀；在酸性条件下，溶解的硫化锌与催化剂对氨基二甲基苯胺 （N,N-dimethyl-p-phenylenediamine）和氯化铁（ferric chloride）反应，产生蓝色的亚甲基蓝（methylene blue）， 通过其终点吸收峰值的变化（670nm波长），来定量分析硫化氢的含量。
美国贝克曼库尔特流式细胞分析仪
美国贝克曼库尔特流式细胞分析仪（Beckman coulter cell）产品型号：Cell Lab Quanta SC当前价格：0.00元产品数量：0新旧程度：全新有效期至：0000-00-00所在地：产品简介：仪器简介：T细胞亚群检测的CD45/CD4/CD8/CD3、CD45/CD56/CD19/CD3；阵发性血红蛋白尿（PNH）检测的CD55、CD59；血小板无力症（GT）检测的CD41、CD61等等详细信息仪器简介：T细胞亚群检测的CD45/CD4/CD8/CD3、CD45/CD56/CD19/CD3；阵发性血红蛋白尿（PNH）检测的CD55、CD59；血小板无力症（GT）检测的CD41、CD61等等。
但对于白血病/淋巴瘤免疫分型，国际上迄今为止也没有统一的抗体组合。
在2000年国际细胞分析学会（ISAC）大会上，临床血细胞计数协会组织了一次国际专家会议，以期对检测血液淋巴系统肿瘤所需最少、最有效的单抗数达成共识。
75%与会者一致认为，对于慢性淋巴系统增殖性疾病（CLD）有9种单抗：CD5,CD19,κ,λ,CD3,CD20,CD23,CD10,CD45对初诊来说是最基本的。
淋巴瘤和CLD相似，需要至少12-16种单抗。
对于急性白血病（AL），75%的与会者认为大约13-15种单抗是最基本的：CD10,CD19,CD79a,CD13,CD33,CD34,CD45,CD2,MPO，CD7,CD14,CD3,HLA-DR等，对初步鉴别白血病系列是必需的。
其他一些（CD16,CD56,CDw65,TdT,cyCD3）可能对某些病例有用。
几乎所有的投票者都认为，要对急性白血病完善分类所需单抗的恰当数量平均为20-24种。
但这些抗体之间组合也是一大难题，目前也无统一规定（如表二）。
大会多数发言者(11/13)指出，对已确诊病人的监护和分期来说，仅需较少单抗。
抗体的质量控制是实验的关键环节。
抗体的质量包括其特异性、灵敏度、精密度。
安捷伦产品目录
15
Real-Time PCR
16
Mx3000P QPCR System
17
Brilliant III Ultra-Fast SYBR Green QPCR and QRT-PCR Reagents
18
Brilliant III Ultra-Fast QPCR and QRT-PCR Reagents
Agilent / STRATAGENE
Agilent website: /genomics
Welgene | Agilent Stratagene
威健股份有限公司 | Stratagene 總代理
Table of Content
Table of Contents
/ XL1-Red Competent Cells SoloPack Gold Supercompetent Cells
/ TK Competent Cells Specialty Cells
/ Classic Cells / Fine Chemicals For Competent Cells
適用於 UNG 去汙染或 bisulphite
sequencing
適用於 TA Cloning
最高敏感性
取代傳統 Taq 的好選擇
-
2
威健股份有限公司 | Stratagene 總代理
PCR Enzyme & Instrument
Agilent SureCycler 8800
市場上領先的 cycling 速度和 sample 體積 10 ～ 100 μL 簡易快速可以選擇 96 well 和 384 well 操作盤 優秀的溫控設備讓各個 well 都能保持溫度的穩定 七吋的高解析度觸控螢幕讓操作上更為簡便 可以透過網路遠端操控儀器及監控儀器 Agilent 專業的技術支援可以幫助您應對各種 PCR 的問題